CAMP4 Therapeutics
Cambridge, MA
CAMP4 Therapeutics is pioneering a new approach to upregulate genes by targeting regulatory RNA using programmable oligonucleotide therapeutics.
camp4tx.comCompany Details
Founded
- 2016
Employees
- Between 50 - 100 employees
Raised
- $240,000,000
Headquarters Location
- Cambridge, MA
Public
- Yes
Acquired
- No
CEO
Josh Mandel-Brehm
Founders
- Leonard ZonRichard Young
Company Collections
These are collections CAMP4 Therapeutics is a part of. Click on the collection name to view similar companies.
CAMP4 Therapeutics' Industries
CAMP4 Therapeutics' Investors
CAMP4 Therapeutics Headquarters Location
1400 West 3rd Floor, Cambridge, MA 02139
Total Amount Raised: $240,000,000
CAMP4 Therapeutics' Investors
CAMP4 Therapeutics Funding Rounds
Post Ipo Equity
$50,000,000
Post Ipo Equity Investors
Coastlands CapitalSynGAP Research FundBalyasny Asset ManagementVivo CapitalJanus Henderson Investors5am VenturesTrails Edge Capital PartnersAdage Capital ManagementIPO
Unknown
Series B
$100,000,000
Series B Investors
Enavate Sciences5am VenturesNorthpond VenturesPolaris PartnersAndreessen HorowitzThe Kraft GroupGaingelsSeries A
$45,000,000
Series A Investors
5am VenturesNorthpond VenturesAndreessen HorowitzThe Kraft GroupPolaris PartnersSeries Unknown
$15,000,000
Series Unknown Investors
BiogenSeries A
$30,000,000
Series A Investors
Andreessen HorowitzPolaris PartnersThe Kraft Group
Funding info provided by Diffbot.
CAMP4 Therapeutics Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on CAMP4 Therapeutics.